Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043
(NASDAQ: PVLA) Delayed: 118.84 +5.74 (5.08%)
Previous Close $113.10    52 Week High $ 
Open $115.29    52 Week Low $ 
Day High $120.88    P/E N/A 
Day Low $114.55    EPS $ 
Volume 231,425